AC8
Pharmaceuticals, Biotechnology & Life Sciences
Auscann Group Holdings
- Short interest
- 0.01%
- 0.00 pp 30d
- as of 21 Feb 2022
- Reported shorts
- 50.9K
- Shares on issue
- 440.547M
Auscann Group Holdings (AC8) company profile
Profile, insiders and operations
Company
AI-generated research profile of Auscann Group Holdings
Medical Cannabis
Pharmaceuticals
Biotechnology
ASX
Healthcare
AusCann Group Holdings Ltd focuses on the cultivation, manufacture, and supply of medical cannabis products. The company aims to provide high-quality, standardized cannabis-based medicines to improve patient outcomes. With a focus on research and development, AusCann seeks to establish itself as a leader in the Australian medical cannabis market.
Director trades
No director trades found
AC8 intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required